News & Events
-
Congressional Testimony 2007
Testimony of FDA officials before House and Senate Committees and Sub-committees.
-
November
- 11/14/2007
Dental Amalgams and the National Environmental Policy Act of 1969
Norris Alderson, Ph.D., before the House Committee on Oversight and Government Reform, Subcommittee on Domestic Policy - 11/13/2007
Food Protection Plan and Import Safety Action Plan
David Acheson, M.D., F.R.C.P., before the Senate Committee on Energy and Commerce, Subcommittee on Oversight and Investigations - 11/01/2007
FDA's Foreign Drug Inspection Program
Andrew C. von Eschenbach, M.D., before the Senate Committee on Energy and Commerce, Subcommittee on Oversight and Investigations
-
-
October
- 10/11/2007
Safety of FDA-regulated Products
David W. K. Acheson, M.D., before the Senate Committee on Energy and Commerce, Subcommittee on Oversight and Investigations - 10/04/2007
Import Safety
Steven M. Solomon, D.V.M., M.P.H., before the House Committee on Ways and Means, Subcommittee on Trade - 10/03/2007
H.R. 1108, Family Smoking Prevention and Tobacco Control Act
Andrew C. von Eschenbach, M.D., before the Senate Committee on Energy and Commerce, Subcommittee on Health
-
-
September
- 09/26/2007
Safety of Imported FDA-regulated Products
Randall Lutter, Ph.D., before the Senate Committee on Energy and Commerce, Subcommittee on Health - 09/25/2007
Food Safety and Food Imports from China
David Acheson, M.D., F.R.C.P., before the House Committee on Appropriations, Subcommittee on Agriculture, Rural Development, FDA and Related Agencies
-
-
July
- 07/24/2007
Food Safety Activities
David Acheson, M.D., F.R.C.P., before the Senate Committee on Homeland Security, Subcommittee on Emerging Threats, Cybersecurity, and Science and Technology - 07/18/2007
Safety of Chinese Imports
Murray M. Lumpkin, M.D., before the Senate Committee on Commerce, Science, and Transportation - 07/17/2007
Alzheimer's Disease: FDA's Role In New Product Development
Andrew C. von Eschenbach, M.D., before the Senate Committee on Health, Education, Labor and Pensions, Subcommittee on Retirement and Aging
-
-
June
- 06/26/2007
Erythropoiesis-Stimulating Agents (ESA)
John K. Jenkins, M.D., before the House Committee on Ways and Means, Subcommittee on Health - 06/12/2007
Hearing on PDUFA, MDUFMA, Drug Safety, and Pediatric Device Legislation
Randall Lutter, Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Health - 06/06/2007
Safety of Rosiglitazone Maleate (Avandia)
Andrew C. von Eschenbach, M.D., before the House Committee on Oversight and Government Reform - 06/01/2007
Critical Path Initiative
Andrew C. von Eschenbach, M.D., before the Senate Committee on Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration and Related Agencies
-
-
May
- 05/22/2007
Programs Affecting Safety and Innovation in Pediatric Therapies
Rear Admiral Sandra Lynn Kweder, M.D., before the House Committee on Energy and Commerce, Subcommittee on Health - 05/16/2007
Implementing MDUFMA
Jeffrey E. Shuren, M.D., J.D., before the House Committee on Energy and Commerce, Subcommittee on Health - 05/15/2007
Fresh Produce and Foodborne Illness Outbreaks
David Acheson, M.D., F.R.C.P., before the House Committee on Agriculture, Subcommittee on Horticulture and Organic Agriculture - 05/09/2007
Strengthening the Science of Drug Safety
Steven Galson, M.D., M.P.H., before the House Committee on Energy and Commerce, Subcommittee on Health - 05/09/2007
Importation of Contaminated Animal Feed Ingredients
David Acheson, M.D., F.R.C.P., before the House Committee on Agriculture - 05/02/2007
Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States
Janet Woodcock, M.D., before the House Committee on Energy and Commerce, Subcommittee on Health - 05/01/2007
Overview of FDA Mission
Andrew C. von Eschenbach, M.D., before the House Committee on Oversight and Government Reform
-
-
April
- 04/25/2007
FDA's Role in Measuring and Assessing Perchlorate Levels in Food and Beverages
Robert E. Brackett, Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Environment and Hazardous Materials - 04/19/2007
Pharmacy Compounding/Compounding of Bio-identical Hormone Replacement Therapies
Steven K. Galson, M.D., M.P.H., before the Senate Special Committee on Aging - 04/18/2007
FDA's Role in Regulating Vaccines
Jesse L. Goodman, M.D., M.P.H., before the Senate Committee on Homeland Security (Appropriations), Subcommittee on Emerging Threats, Cybersecurity, and Science and Technology - 04/17/2007
Prescription Drug User Fee Act (PDUFA)
Theresa M. Mullin, Ph.D., before the House Committee on Energy and Commerce, Subcommittee on Health - 04/12/2007
Contamination of Pet Food
Stephen F. Sundlof, D.V.M., Ph.D., before the Senate Committee on Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
-
-
March
- 03/26/2007
Follow-on Protein Products
Janet Woodcock, M.D., before the House Committee on Oversight and Government Reform - 03/22/2007
The Future of FDA's Drug Safety Program
Andrew C. von Eschenbach, M.D., before the House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations - 03/14/2007
FDA's Success in Implementing PDUFA
Andrew C. von Eschenbach, M.D., before the Senate Committee on Health, Education, Labor and Pensions - 03/12/2007
FDA's Planned Improvements for Food Safety
Andrew C. von Eschenbach, M.D., before the Senate Committee on Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies - 03/07/2007
Policy Implications of Importing Drugs in the United States
Randall W. Lutter, Ph.D., before the Senate Committee on Commerce, Science, and Transportation, Subcommittee on Interstate Commerce, Trade, and Tourism
-
-
February
- 02/27/2007
Fiscal Year 2008 FDA Budget Request
Andrew C. von Eschenbach, M.D., before the Senate Committee on Appropriations, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
-
-
-